{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:10:31Z","timestamp":1790079031171,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010449","name":"Nationales Centrum f\u00fcr Tumorerkrankungen Heidelberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejca.2018.12.023","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T06:04:37Z","timestamp":1549778677000},"page":"11-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases"],"prefix":"10.1016","volume":"110","author":[{"given":"Ricarda","family":"Rauschenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Br\u00fctting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Daubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Forschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Berking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina C.","family":"Kaehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Utikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gutzmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Terheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Meiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rafei-Shamsabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kiecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Dabrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Garzarolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Kuske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Beissert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"L\u00f6ck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Linn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther G.C.","family":"Troost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedegund","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2018.12.023_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib2","first-page":"1","article-title":"Melanoma brain metastases: local therapies, targeted therapies, immune checkpoint inhibitors and their combinations\u2014chances and challenges","author":"Kuske","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ejca.2018.12.023_bib3","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/S1470-2045(18)30439-X","article-title":"Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation","volume":"19","author":"Kruser","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00008390-200302000-00016","article-title":"A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma","volume":"13","author":"Mornex","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2018.12.023_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/COC.0b013e3181c4c54b","article-title":"Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?","volume":"33","author":"Schild","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2018.12.023_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-014-1533-z","article-title":"Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib","volume":"120","author":"Peuvrel","year":"2014","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.canrad.2014.06.012","article-title":"Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives","volume":"18","author":"Rekers","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ejca.2018.12.023_bib11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2018.12.023_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijrobp.2012.03.017","article-title":"The abscopal effect associated with a systemic anti-melanoma immune response","volume":"85","author":"Stamell","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.12.023_bib13","first-page":"5","article-title":"Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: a systematic review","volume":"9","author":"Chicas-Sett","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib14","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","article-title":"Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated","volume":"58","author":"Demaria","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.12.023_bib15","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/annonc\/mdv139","article-title":"Radiosensitization by BRAF inhibitor therapy-mechanism and frequency of toxicity in melanoma patients","volume":"26","author":"Hecht","year":"2015","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.radonc.2010.12.017","article-title":"Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032","volume":"98","author":"Sambade","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib17","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1200\/JCO.2012.44.4265","article-title":"Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy","volume":"31","author":"Satzger","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","article-title":"The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies","volume":"133","author":"Kim","year":"2017","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11060-017-2470-4","article-title":"Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma","volume":"133","author":"Fang","year":"2017","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejca.2017.01.007","article-title":"Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies","volume":"75","author":"Choong","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.12.023_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejca.2017.07.017","article-title":"Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery","volume":"84","author":"Gaudy-Marqueste","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2018.12.023_bib22","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/annonc\/mdw417","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF\/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/pcmr.12682","article-title":"Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy","volume":"31","author":"Tio","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ejca.2018.12.023_bib24","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/cncr.30138","article-title":"Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery","volume":"122","author":"Qian","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2018.12.023_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-017-2695-2","article-title":"Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy","volume":"137","author":"Fang","year":"2018","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/annonc\/mdv622","article-title":"Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy","volume":"27","author":"Ahmed","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib27","doi-asserted-by":"crossref","first-page":"E1540","DOI":"10.1073\/pnas.1714089115","article-title":"Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking","volume":"115","author":"Taggart","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ejca.2018.12.023_bib28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.bjc.6605622","article-title":"Determinants of survival in patients with brain metastases from cutaneous melanoma","volume":"102","author":"Staudt","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2018.12.023_bib29","doi-asserted-by":"crossref","DOI":"10.3238\/arztebl.2016.0415","article-title":"The interdisciplinary management of brain metastases","author":"Schmieder","year":"2016","journal-title":"Dtsch Aerzteblatt Online"},{"key":"10.1016\/j.ejca.2018.12.023_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2004.02.019","article-title":"Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients","volume":"71","author":"Broadbent","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00066-014-0808-9","article-title":"Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: local tumour control and survival","volume":"191","author":"Oehlke","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ejca.2018.12.023_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2006.01.024","article-title":"Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy","volume":"65","author":"Gaudy-Marqueste","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.12.023_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3171\/2014.9.JNS141425","article-title":"Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment","volume":"123","author":"Ly","year":"2015","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ejca.2018.12.023_bib36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11060-016-2072-6","article-title":"Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases","volume":"127","author":"Wolf","year":"2016","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-014-1685-x","article-title":"LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases","volume":"122","author":"Ahmed","year":"2015","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib38","first-page":"A358.1","volume":"vol. 3","author":"Shannan","year":"2018"},{"key":"10.1016\/j.ejca.2018.12.023_bib39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/bjc.2017.489","article-title":"Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients","volume":"118","author":"Hecht","year":"2018","journal-title":"Br\u00a0J Cancer"},{"key":"10.1016\/j.ejca.2018.12.023_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2017.03.030","article-title":"The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases","volume":"98","author":"Sperduto","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2018.12.023_bib41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11060-015-1881-3","article-title":"Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases","volume":"125","author":"Kohutek","year":"2015","journal-title":"J Neuro Oncol"},{"issue":"abstr","key":"10.1016\/j.ejca.2018.12.023_bib42","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1200\/JCO.2017.35.15_suppl.9552","article-title":"Safety and results of anti-PD1 combined with radiosurgery for the treatment of melanoma brain metastases","volume":"35","author":"Gaudy Marqueste","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejca.2018.12.023_bib44","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2015-02-626788","article-title":"Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study","volume":"126","author":"Donato","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2018.12.023_bib45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14737175.2016.1184572","article-title":"Radionecrosis after stereotactic radiotherapy for brain metastases","volume":"16","author":"Le Rhun","year":"2016","journal-title":"Expert Rev Neurother"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918315788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918315788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:34:34Z","timestamp":1762342474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918315788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":45,"alternative-id":["S0959804918315788"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.023","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}